Eric Aguiar's most recent trade in BridgeBio Pharma Inc was a trade of 8,425 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 8,425 | 8,425 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 6,589 | 6,589 (0%) | 0% | 0 | Common Stock | |
| Biomea Fusion Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 91,970 | 91,970 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 26,014 | 26,014 | - | - | Stock Option (Right to Buy) | |
| Biomea Fusion Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 51,025 | 51,025 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 51,501 | 51,501 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 70,422 | 125,322 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 28,901 | 28,901 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| Biomea Fusion Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,867 | 23,867 | - | - | Stock Option (Right to Buy) | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 32,100 | 43,600 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 16,100 | 16,100 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 11,300 | 54,900 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 5,700 | 5,700 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 38,895 | 38,895 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 8,500 | 8,500 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 4,400 | 4,400 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 3,000 | 11,500 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 1,500 | 1,500 | - | - | Stock Option (right to buy) | |
| Biomea Fusion Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 28,911 | 28,911 | - | - | Stock Option (Right to Buy) | |
| Invitae Corp | Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.16 per share. | 16 Dec 2020 | 10,000 | 10,000 (0%) | 0% | 24.2 | 241,600 | Common Stock |
| Invitae Corp | Eric Aguiar | Director | Sale of securities on an exchange or to another person at price $ 50.74 per share. | 16 Dec 2020 | 6,400 | 3,600 (0%) | 0% | 50.7 | 324,723 | Common Stock |
| Invitae Corp | Eric Aguiar | Director | Sale of securities on an exchange or to another person at price $ 51.47 per share. | 16 Dec 2020 | 3,600 | 0 (0%) | 0% | 51.5 | 185,280 | Common Stock |
| Invitae Corp | Eric Aguiar | Director | Sale of securities on an exchange or to another person at price $ 46.36 per share. | 16 Nov 2020 | 22,883 | 7,117 (0%) | 0% | 46.4 | 1,060,856 | Common Stock |
| Invitae Corp | Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.51 per share. | 16 Nov 2020 | 10,000 | 10,000 (0%) | 0% | 8.5 | 85,100 | Common Stock |
| Invitae Corp | Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.18 per share. | 16 Nov 2020 | 10,000 | 20,000 (0%) | 0% | 9.2 | 91,800 | Common Stock |
| Invitae Corp | Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.13 per share. | 16 Nov 2020 | 10,000 | 30,000 (0%) | 0% | 11.1 | 111,300 | Common Stock |
| Invitae Corp | Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Eric Aguiar | Director | Sale of securities on an exchange or to another person at price $ 47.05 per share. | 16 Nov 2020 | 7,117 | 0 (0%) | 0% | 47.1 | 334,855 | Common Stock |
| Invitae Corp | Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.08 per share. | 15 Jul 2020 | 10,000 | 10,000 (0%) | 0% | 8.1 | 80,800 | Common Stock |
| Invitae Corp | Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2020 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Eric Aguiar | Director | Sale of securities on an exchange or to another person at price $ 34.24 per share. | 15 Jul 2020 | 6,829 | 0 (0%) | 0% | 34.2 | 233,814 | Common Stock |
| Invitae Corp | Eric Aguiar | Director | Sale of securities on an exchange or to another person at price $ 33.44 per share. | 15 Jul 2020 | 3,171 | 6,829 (0%) | 0% | 33.4 | 106,039 | Common Stock |